This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Looker, H. C. Articles by Hanson, R. L. Search for Related Content PubMed PubMed Citation Articles by Looker, H. C. Articles by Hanson, R. L.

Adiponectin Concentrations Are Influenced by Renal Function and Diabetes Duration in Pima Indians with Type 2 Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (H.C.L., J.K., R.G.N., W.C.K., R.S.L., R.L.H.), Phoenix, Arizona 85014; Department of Internal Medicine and Molecular Science (T.F., Y.M., S.T.), Graduate School of Medicine, Osaka University, Japan 565-0871; and University of Glasgow (R.S.L.), Glasgow, United Kingdom G11 6NT

Address all correspondence and requests for reprints to: Helen C. Looker, National Institute of Diabetes and Digestive and Kidney Diseases, 1550 East Indian School Road, Phoenix, Arizona 85014. E-mail: hlooker{at}mail.nih.gov.

Adiponectin is produced exclusively by adipocytes, and its serum concentration is inversely associated with adiposity. This study examines the relationship among diabetes, renal function, and serum adiponectin in Pima Indians. Serum adiponectin was measured in 1069 people in whom glycemia and renal function had been measured. Serum adiponectin, adjusted for age, sex, and body mass index, was lowest in those with impaired glucose regulation or diabetes of less than 10 yr duration and highest in those with normal glucose tolerance or diabetes of duration of at least 10 yr. Both urinary albumin to creatinine ratio (ACR) and serum creatinine were positively correlated with adiponectin (Spearman’s r = 0.43; P < 0.0001, and r = 0.37; P < 0.0001, respectively) in diabetic subjects. After stratification by albuminuria (normoalbuminuria ACR < 30 mg/g, microalbuminuria ACR = 30–299 mg/g, and macroalbuminuria ACR 300 mg/g), the highest adiponectin concentration was in the macroalbuminuria group (geometric mean = 9.6 µg/ml) and the lowest was in the normoalbuminuric group (geometric mean = 5.6 µg/ml). After adjustment for age, sex, body mass index, and diabetes duration, the serum adiponectin concentration in the macroalbuminuria group was significantly higher than in both other groups (P < 0.0001). Serum adiponectin is lowest in the presence of impaired glucose regulation and early diabetes. In the presence of diabetes, serum adiponectin is positively associated with abnormal renal function and diabetes duration.

Abbreviations: ACR, Albumin to creatinine ratio; BMI, body mass index; GFR, glomerular filtration rate; HbA_1c, hemoglobin A_1c; IGR, impaired glucose regulation; MAP, mean arterial blood pressure; NGR, normal glucose regulation.

This article has been cited by other articles:

				M. von Eynatten, D. Liu, C. Hock, D. Oikonomou, M. Baumann, B. Allolio, G. Korosoglou, M. Morcos, V. Campean, K. Amann, et al. Urinary Adiponectin Excretion: A Novel Marker for Vascular Damage in Type 2 Diabetes Diabetes, September 1, 2009; 58(9): 2093 - 2099. [Abstract] [Full Text] [PDF]

				L. L. Guo, Y. Pan, and H. M. Jin Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1876 - 1883. [Abstract] [Full Text] [PDF]

				C. Maric Sex, diabetes and the kidney Am J Physiol Renal Physiol, April 1, 2009; 296(4): F680 - F688. [Abstract] [Full Text] [PDF]

				C. Zoccali and F. Mallamaci Obesity, diabetes, adiponectin and the kidney: a podocyte affair Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3767 - 3770. [Full Text] [PDF]

				S. H. Ley, S. B. Harris, P. W. Connelly, M. Mamakeesick, J. Gittelsohn, R. A. Hegele, R. Retnakaran, B. Zinman, and A. J.G. Hanley Adipokines and Incident Type 2 Diabetes in an Aboriginal Canadian Population: The Sandy Lake Health and Diabetes Project Diabetes Care, July 1, 2008; 31(7): 1410 - 1415. [Abstract] [Full Text] [PDF]

				K. J. Williams, G. Qiu, H. K. Usui, S. R. Dunn, P. McCue, E. Bottinger, R. V. Iozzo, and K. Sharma Decorin Deficiency Enhances Progressive Nephropathy in Diabetic Mice Am. J. Pathol., November 1, 2007; 171(5): 1441 - 1450. [Abstract] [Full Text] [PDF]

				V. B. O'Leary, A. E. Jorett, C. M. Marchetti, F. Gonzalez, S. A. Phillips, T. P. Ciaraldi, and J. P. Kirwan Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E421 - E427. [Abstract] [Full Text] [PDF]

				J. Lin, F. B. Hu, and G. Curhan Serum Adiponectin and Renal Dysfunction in Men With Type 2 Diabetes Diabetes Care, February 1, 2007; 30(2): 239 - 244. [Abstract] [Full Text] [PDF]

				J. Frystyk, C. Berne, L. Berglund, K. Jensevik, A. Flyvbjerg, and B. Zethelius Serum Adiponectin Is a Predictor of Coronary Heart Disease: A Population-Based 10-Year Follow-Up Study in Elderly Men J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 571 - 576. [Abstract] [Full Text] [PDF]

				T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto Type 1 diabetes and coronary artery disease. Diabetes Care, November 1, 2006; 29(11): 2528 - 2538. [Full Text] [PDF]

				V. Menon, L. Li, X. Wang, T. Greene, V. Balakrishnan, M. Madero, A. A. Pereira, G. J. Beck, J. W. Kusek, A. J. Collins, et al. Adiponectin and Mortality in Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2599 - 2606. [Abstract] [Full Text] [PDF]

				R. K. Semple, M. A. Soos, J. Luan, C. S. Mitchell, J. C. Wilson, M. Gurnell, E. K. Cochran, P. Gorden, V. K. K. Chatterjee, N. J. Wareham, et al. Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3219 - 3223. [Abstract] [Full Text] [PDF]

				C. G. Schalkwijk, N. Chaturvedi, M. T. Schram, J. H. Fuller, C. D. A. Stehouwer, and the EURODIAB Prospective Complications Study Group Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 129 - 135. [Abstract] [Full Text] [PDF]

				T. Isobe, S. Saitoh, S. Takagi, H. Takeuchi, Y. Chiba, N. Katoh, and K. Shimamoto Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study Eur. J. Endocrinol., July 1, 2005; 153(1): 91 - 98. [Abstract] [Full Text] [PDF]

				M. Saraheimo, C. Forsblom, J. Fagerudd, A.-M. Teppo, K. Pettersson-Fernholm, J. Frystyk, A. Flyvbjerg, P.-H. Groop, and on behalf of the FinnDiane Study Group Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy Diabetes Care, June 1, 2005; 28(6): 1410 - 1414. [Abstract] [Full Text] [PDF]

				R. S. Lindsay, H. E. Resnick, J. Zhu, M. L. Tun, B. V. Howard, Y. Zhang, J. Yeh, and L. G. Best Adiponectin and Coronary Heart Disease: The Strong Heart Study Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): e15 - e16. [Full Text] [PDF]

				B. Vozarova de Courten, R. L. Hanson, T. Funahashi, R. S. Lindsay, Y. Matsuzawa, S. Tanaka, F. Thameem, J. D. Gruber, P. Froguel, and J. K. Wolford Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians Diabetes, January 1, 2005; 54(1): 284 - 289. [Abstract] [Full Text] [PDF]